Evidence map›Paper›PMID 17307700›Full record

ReviewImmunity2007

Formin the way.

Pamela L Schwartzberg

Abstract readReviewComment
PubMed Publisher
In one paragraph

Review in Immunity, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

1 author.

Pamela L SchwartzbergNational Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA. pams@mail.nih.gov

Funding

Genetic and Biochemical Approaches to Tyrosine Kinase FunctionZIAHG000123 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SCHWARTZBERG, PAMELA · 2009 to 2018
$20.8M
Genetic/Biochemical Approaches-Tyrosine Kinase FunctionZ01HG000123 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SCHWARTZBERG, PAMELA · 1998 to 2008
$4.7M
6 · The paper itself

Abstract

Reorganization of the actin cytoskeleton requires nucleating factors, which initiate actin fiber formation. In this issue of Immunity, the functions of two classes of actin nucleators are examined in T lymphocytes, giving insight into the regulation of T cell polarity (Gomez et al., 2007).

Indexed as

Actin-Related Protein 2-3 ComplexActinsAdaptor Proteins, Signal TransducingAnimalsCell PolarityCytoskeletal ProteinsCytoskeletonForminsHumansLymphocyte ActivationT-LymphocytesActin-Related Protein 2-3 ComplexActinsAdaptor Proteins, Signal TransducingCytoskeletal ProteinsDIAPH1 protein, humanFMNL1 protein, humanFormins

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.